Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Jewels get FDA clearance:

This article was originally published in Clinica

Executive Summary

The US FDA has cleared two of Medtronic's Jewel defibrillators for commercial release. Jewel models 7219C and 7202C use Medtronic's active can technology which, in clinical trials of 475 patients significantly lowered average defibrillation thresholds. The single Transvene lead system reduces extraneous electrical noise which could be misinterpreted by the circuitry, says Medtronic. Model 7202C offers cardioversion and defibrillation, while the 7219C also offers anti-tachycardia pacing.

Topics

UsernamePublicRestriction

Register

MT094466

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel